Sun Pharma Profit Falls on Costs Tied to Organon Deal
Sun Pharma said profit fell due to expenses related to its Organon transaction, while specialty drug sales remained solid.
Related stories
Colgate-Palmolive Reports 4.6% Sales Growth, $0.97 Adjusted EPS
Third-quarter 2026 net sales were $5.369 billion, up 4.6% year over year. Gross margin rose to 60.2%, and Base Business diluted EPS increased 7% to $0.97. The company narrowed its
H impact | EARNINGS | Oct 30, 2026, 12:03 PM UTC
Erste Bank earnings below expectations at 2.74 EUR
Erste Bank (EBS) released earnings per share at 2.74 EUR, compared to market expectations of 2.77 EUR.
H impact | EARNINGS | Oct 30, 2026, 12:02 PM UTC
Natwest earnings in line with market expectations at 0.19 GBP
Natwest (NWG) released earnings per share at 0.19 GBP, in line with market expectations.
H impact | EARNINGS | Oct 30, 2026, 12:02 PM UTC
Credit Agricole earnings above expectations at 0.62 EUR
Credit Agricole (ACA) released earnings per share at 0.62 EUR, compared to market expectations of 0.55 EUR.
H impact | EARNINGS | Oct 30, 2026, 12:02 PM UTC
ConocoPhillips Q3 2026 Earnings
H impact | EARNINGS | Oct 30, 2026, 12:01 PM UTC
McDonald's Q3 2026 Earnings
H impact | EARNINGS | Oct 30, 2026, 12:00 PM UTC